These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8218955)

  • 1. Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol.
    Shyu WC; Mayol RF; Pfeffer M; Pittman KA; Gammans RE; Barbhaiya RH
    Biopharm Drug Dispos; 1993 Jul; 14(5):371-9. PubMed ID: 8218955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
    Shyu WC; Pittman KA; Robinson DS; Barbhaiya RH
    Eur J Clin Pharmacol; 1993; 45(6):559-62. PubMed ID: 8157043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.
    Shyu WC; Morgenthien EA; Pittman KA; Barbhaiya RH
    Eur J Clin Pharmacol; 1994; 47(1):57-60. PubMed ID: 7988625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management.
    Gillis JC; Benfield P; Goa KL
    Drugs; 1995 Jul; 50(1):157-75. PubMed ID: 7588085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of intranasal butorphanol administered from a single-dose sprayer.
    Davis GA; Rudy AIa; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2005 Jan; 62(1):48-53. PubMed ID: 15658072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration.
    Wells SM; Glerum LE; Papich MG
    Am J Vet Res; 2008 Dec; 69(12):1548-54. PubMed ID: 19045999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose phase I study of transnasal butorphanol.
    Shyu WC; Pittman KA; Robinson D; Barbhaiya RH
    Clin Pharmacol Ther; 1993 Jul; 54(1):34-41. PubMed ID: 8330463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
    Davis GA; Rudy AC; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2004 Feb; 61(3):261-6. PubMed ID: 14986556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
    Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
    Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of butorphanol nasal spray in patients with renal impairment.
    Shyu WC; Morgenthien EA; Barbhaiya RH
    Br J Clin Pharmacol; 1996 May; 41(5):397-402. PubMed ID: 8735680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of butorphanol after intravenous, intramuscular, and oral administration in Hispaniolan Amazon parrots (Amazona ventralis).
    Guzman DS; Flammer K; Paul-Murphy JR; Barker SA; Tully TN
    J Avian Med Surg; 2011 Sep; 25(3):185-91. PubMed ID: 22216718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transnasal butorphanol.
    Homan RV
    Am Fam Physician; 1994 Jan; 49(1):188-92. PubMed ID: 7993396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of transnasal butorphanol tartrate in postepisiotomy pain: a model to assess analgesia.
    Joyce TH; Kubicek MF; Skjonsby BS; Jones MM
    Clin Ther; 1993; 15(1):160-7. PubMed ID: 8458045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate.
    Srinivas NR; Shyu WC; Upmalis D; Lee JS; Barbhaiya RH
    J Clin Pharmacol; 1995 Apr; 35(4):432-7. PubMed ID: 7650235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses.
    Chiavaccini L; Claude AK; Lee JH; Ross MK; Meyer RE; Langston VC
    J Vet Pharmacol Ther; 2015 Aug; 38(4):365-74. PubMed ID: 25484250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of butorphanol in llamas after intravenous and intramuscular administration.
    Carroll GL; Boothe DM; Hartsfield SM; Martinez EA; Spann AC; Hernandez A
    J Am Vet Med Assoc; 2001 Nov; 219(9):1263-7. PubMed ID: 11697372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine.
    Shyu WC; Barbhaiya RH
    Br J Clin Pharmacol; 1996 Oct; 42(4):513-7. PubMed ID: 8904627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and milk residues of butorphanol in dairy cows after single intravenous administration.
    Court MH; Dodman NH; Levine HD; Richey MT; Lee JW; Hustead DR
    J Vet Pharmacol Ther; 1992 Mar; 15(1):28-35. PubMed ID: 1573703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes.
    Frye LJ; Byrne ME; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):265-8. PubMed ID: 27102981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interaction between butorphanol nasal spray and oral metoclopramide in healthy women.
    Vachharajani NN; Shyu WC; Barbhaiya RH
    J Clin Pharmacol; 1997 Oct; 37(10):979-85. PubMed ID: 9505990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.